Published in BMC Geriatr on November 25, 2016
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
A new rating scale for Alzheimer's disease. Am J Psychiatry (1984) 15.16
Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist (1980) 9.19
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. N Engl J Med (2014) 6.67
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med (2014) 6.50
An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord (1997) 5.94
A phase 3 trial of semagacestat for treatment of Alzheimer's disease. N Engl J Med (2013) 4.11
Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients. Alzheimers Dement (2015) 1.34
The cost of dementia in Europe: a review of the evidence, and methodological considerations. Pharmacoeconomics (2009) 1.28
Cost-of-illness studies of dementia: a systematic review focusing on stage dependency of costs. Acta Psychiatr Scand (2009) 1.27
Detailed assessment of activities of daily living in moderate to severe Alzheimer's disease. J Int Neuropsychol Soc (2005) 1.13
Cross sectional observational study on the societal costs of Alzheimer's disease. Curr Alzheimer Res (2010) 1.00
Predictors of institutionalization in dementia: a three year longitudinal study. J Alzheimers Dis (2014) 0.99
The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings. J Alzheimers Dis (2013) 0.98
Evaluation of full costs of care for patients with Alzheimer's disease in France: the predominant role of informal care. Health Policy (2014) 0.96
Costs of care for people with dementia just before and after nursing home placement: primary data from eight European countries. Eur J Health Econ (2014) 0.95
Retrospective analyses of large medical databases: what do they tell us? J Am Soc Nephrol (1999) 0.94
Determinants of societal costs in Alzheimer's disease: GERAS study baseline results. Alzheimers Dement (2015) 0.92
Modeling the time-course of Alzheimer dementia. Curr Psychiatry Rep (2001) 0.91
Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria. J Intern Med (2014) 0.88
Caregiver Burden in Alzheimer's Disease: Differential Associations in Adult-Child and Spousal Caregivers in the GERAS Observational Study. Dement Geriatr Cogn Dis Extra (2014) 0.86
Progression of Alzheimer disease in Europe: data from the European ICTUS study. Curr Alzheimer Res (2012) 0.85
Relationship between global severity of patients with Alzheimer's disease and costs of care in Spain; results from the co-dependence study in Spain. Eur J Health Econ (2014) 0.83
The reliability of assigning individuals to cognitive states using the Mini Mental-State Examination: a population-based prospective cohort study. BMC Med Res Methodol (2011) 0.79
Medical management, costs, and consequences of Alzheimer's disease in Germany: an analysis of health claims data. J Med Econ (2015) 0.78
How to deal with missing longitudinal data in cost of illness analysis in Alzheimer's disease-suggestions from the GERAS observational study. BMC Med Res Methodol (2016) 0.75
How useful is the EQ-5D in assessing the impact of caring for people with Alzheimer's disease? Health Qual Life Outcomes (2017) 0.75